Login to Your Account

House Committee Investigating ImClone’s Handling Of Erbitux

By Kim Coghill

Tuesday, January 22, 2002
WASHINGTON A House committee on Friday said it will investigate New York-based ImClone Systems Inc.’s conduct in the development of its well-publicized drug for colorectal cancer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription